Drug Approval | July 26, 2023
NATCO files generic Erdafitinib Tablets in USA
Erdafitinib is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma
Erdafitinib is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma
Shivalik Rasayan Limited has issued LOA to Medicamen Biotech to use its DMF grade Bortezomib API for formulation of Bortezomib injection 3.5mg/ vial
This product will be launched through Granules Consumer Health (GCH) division
USFDA concludes inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
This trial is a multi-national, phase 2/3, open-label, randomized, controlled clinical study of utidelone injectable
Thiamine Hydrochloride Injection USP had estimated annual sales of USD 35 million in the U.S.
The inspection closed with the facility receiving an inspection classification of NAI
Based on a subgroup analysis by PD-L1 expression from KEYNOTE-811, Merck is working with the US FDA to update the current indication for KEYTRUDA in HER2-positive gastric or GEJ adenocarcinoma
Panacea Biotec has announced the launch of its new range of high-quality pediatric food & nutritional products
Subscribe To Our Newsletter & Stay Updated
